2m 2m 2m 2m 2m 2m 2m
Emergent BioSolu (EBS)
NYSE
$5.05-$0.03 (-0.61%)
Price as of Aug 21, 2026 7:55 PM EDT- $260.5MMarket Cap
- -44.96%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent BioSolu (EBS)
$5.05-$0.03 (-0.61%)
EBS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.08 | ||
Change | +$0.26 (+5.39%) | ||
Open | $4.79 | ||
High | $5.11 | ||
Low | $4.75 | ||
Previous Close | $4.82 | ||
Volume | 1,418,590 | ||
30-Day Average Volume | 1,290,083 | ||
1-Week Change | 10.68% | ||
1-Month Change | -33.59% | ||
1-Year Change | -44.96% | ||
3-Year Change | 6.72% | ||
5-Year Change | -91.97% | ||
Fundamentals | |||
Shares Outstanding | 51.3M | ||
Total Assets | $1.1B | ||
Market Cap | $260.5M | ||
Enterprise Value | $702.6M | ||
Period: QTR TTM FY | |||
Revenue | $226.8M | ||
Net Income | -$180.2M | ||
Free Cash Flow | $54.0M | ||
EBIT | -$166.3M | ||
EBITDA | -$142.3M | ||
Net Working Capital | $543.2M | ||
EPS | -$3.49 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | 5 | ||
Price/Operating Cash Flow | 5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue